The Department of Health and Human Services (HHS), through the Biomedical Advanced R&D Authority (BARDA) has awarded Pfenex, Inc. a contract valued at $18.8 million in funding based on the achievement of milestones and that all contract options and extensions are exercised by the government. The contract supports the development of a Pfenex Expression Technology-based production strain and process for the production of bulk recombinant protective antigen (rPA) from anthrax. Pfenex will a...